zintick

← Oruka Therapeutics (ORKA)

Oruka Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KOct. 26, 2026, 8 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedOruka Therapeutics Reports Positive Week 16 EVERLAST-B Results for ORKA-001: 61% PASI 100 at 600 mg vs. 0% Placebo

  • 8-KAug. 24, 2026, 4:06 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Financial statements and exhibits

  • 8-KAug. 10, 2026, 7 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits